<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03828253</url>
  </required_header>
  <id_info>
    <org_study_id>pAVF 1.0</org_study_id>
    <nct_id>NCT03828253</nct_id>
  </id_info>
  <brief_title>Ellipsys Fistula for Hemodialysis Access</brief_title>
  <official_title>Ellipsys Percutaneous Arteriovenous Fistula for Hemodialysis Access</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Richmond Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Richmond Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To report the outcomes of patients having percutaneous proximal radial artery fistula
      creation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study would like to enroll up to 100 patients without age, gender-based, race and
      ethnicity enrollment restrictions for adults over 18 years of age. Women of child bearing
      potential are not excluded. If a pregnant patient required, an arteriovenous fistula for
      hemodialysis an Ellipsys速 fistula would be an option. The Investigator would like to consent
      previous Ellipsys速 patients with appropriate medical records so that the Investigator may
      capture participants data for outcomes reporting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2018</start_date>
  <completion_date type="Anticipated">August 27, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 27, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Blood flow Volume</measure>
    <time_frame>90 days</time_frame>
    <description>Brachial Artery flow volume of 500ml as measured on Ultrasound Duplex</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>ESRD</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Recruitment of subjects will be from the current End Stage Renal disease patient population
        at Richmond Vascular Center and referrals from Nephrologists and Vascular Surgeons.

        The study would like to enroll up to 100 patients without age, gender-based, race and
        ethnicity enrollment restrictions for adults over 18 years of age. Women of child bearing
        potential are not excluded. If a pregnant patient required, an arteriovenous fistula for
        hemodialysis an Ellipsys速 fistula would be an option. We would like to consent previous
        Ellipsys速 patients with appropriate medical records so that we may capture their data for
        outcomes reporting.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age &gt; 18 years or older

          -  Diagnosed with ESRD or chronic kidney disease requiring dialysis or anticipating start
             of dialysis

          -  Adjacent vein diameter of &gt; 2.0 mm at target anastomosis site and confirmed clinically
             significant outflow

          -  Arterial lumen diameter of &gt; 2.0 mm at target anastomosis site

          -  Adequate collateral arterial perfusion: Barbeau test grade A through C

          -  Radial artery -adjacent vein proximity &lt; 1.5 mm measured lumen edge-to-lumen edge via
             ultrasound

        Exclusion Criteria:

          -  Target vessel that are &lt; 2mm is diameter

          -  Distance between the target artery and vein &gt; 1.5 mm

          -  Edema of the upper extremity on the ipsilateral side

          -  Barbeau test grade D
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Hull, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Richmond Vascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tricia Eichenlaub, RN</last_name>
    <phone>804-864-8346</phone>
    <email>Teichenlaub@Richmondvascularcenter.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brittani Lewis</last_name>
    <phone>804-864-8346</phone>
    <email>Blewis@Richmondvascularcenter.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Richmond Vascular Center</name>
      <address>
        <city>North Chesterfield</city>
        <state>Virginia</state>
        <zip>23236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tricia Eichenlaub, RN</last_name>
      <phone>804-864-8346</phone>
      <email>Teichenlaub@richmondvascularcenter.com</email>
    </contact>
    <contact_backup>
      <last_name>Brittani Lewis</last_name>
      <phone>804-864-8346</phone>
      <email>Blewis@Richmondvascularcenter.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Hull, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 18, 2018</study_first_submitted>
  <study_first_submitted_qc>January 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2019</study_first_posted>
  <last_update_submitted>January 31, 2019</last_update_submitted>
  <last_update_submitted_qc>January 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

